Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

Overview of attention for article published in Molecular Cancer Therapeutics, October 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
twitter: 17 X users

patent: 4 patents

Citations

dimensions_citation: 295 Dimensions

Readers on

mendeley: 266 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

TARGETED PROTEIN DEGRADATION

Application WO-2020132561-A1

World Intellectual Property Organisation (WIPO)

C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

Application WO-2017197046-A1

World Intellectual Property Organisation (WIPO)

HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

Application WO-2017197055-A1

World Intellectual Property Organisation (WIPO)

SPIROCYCLIC DEGRONIMERS FOR TARGET PROTEIN DEGRADATION

Application WO-2017197036-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.